February 28, 2025
Headlines

TECHNOLOGY

Antiverse Secures £3.5M to Revolutionize Antibody Design and Address Complex Therapeutic Targets

Editor05 mins

Antiverse, a forward-thinking techbio company focused on antibody design for challenging therapeutic targets, has successfully raised an additional £3.5M ($4.6M) in its latest funding round. This investment elevates the total funding to £7.2M ($10.1M) and will significantly bolster Antiverse’s growth initiatives, including the expansion of its research facilities in Boston and Prague. The funding was…

Read More

Tolerance Bio, Inc. Secures $17.2 Million Seed Financing to Revolutionize Thymus-Based Therapies for Immune Disorders

Editor05 mins

In a significant development for the biopharmaceutical landscape, Tolerance Bio, Inc. has announced the successful closure of its oversubscribed $17.2 million seed financing round. Spearheaded by Columbus Venture Partners, this funding will accelerate the company’s innovative work on thymus preservation, regeneration, and manipulation therapies aimed at treating a range of immune-mediated diseases. Founded by industry…

Read More

Xscape Photonics Secures $44 Million in Series A Funding to Transform AI Data Centers

Editor010 mins

In a significant step towards revolutionizing the architecture of AI data centers, Xscape Photonics has announced the successful closing of a $44 million Series A funding round. This financing, led by IAG Capital Partners, attracted contributions from prominent investors including Cisco Investments, NVIDIA, Altair, Fathom Fund, Kyra Ventures, LifeX Ventures, and OUP. The total funding…

Read More

Shift Bioscience Secures $16M to Revolutionize Age-Related Disease Treatment Through AI-Driven Gene Rejuvenation

Editor05 mins

In a significant advancement for the biotechnology sector, Shift Bioscience has successfully raised $16 million (£12.5 million) in Seed funding, spearheaded by BGF and joined by prominent existing investors including F-Prime Capital, Kindred Capital, and Jonathan Milner. This investment is poised to accelerate the development of Shift Bioscience’s innovative artificial intelligence platform aimed at identifying…

Read More

Empatha Gains Momentum with New Funding to Transform Behavioral Health in Workers’ Compensation

Editor05 mins

In a significant step to enhance the delivery of behavioral health services within the workers’ compensation sector, Empatha, a frontrunner in behavioral care management, has announced a successful capital raise from institutional investors. This infusion of funds is poised to bolster Empatha’s capacity to serve the increasing needs of injured workers, employers, and insurers, as…

Read More

Decagon Raises $100 Million to Redefine AI-Driven Customer Support

Editor05 mins

Decagon, a trailblazer in AI-powered customer support solutions, has successfully raised $100 million in total funding, bolstered by a recent $65 million Series B round led by Bain Capital Ventures. This impressive financial milestone has quadrupled the company’s valuation in a short span, solidifying its role in transforming enterprise customer support and enhancing productivity across…

Read More

Zinnia Secures $300 Million in Strategic Financing to Transform Life and Annuity Market

Editor05 mins

In a significant move poised to reshape the life and annuity (L&A) insurance technology landscape, Zinnia, a leading innovator in the sector, has successfully raised $300 million in strategic financing from Vista Credit Partners, a subsidiary of Vista Equity Partners. This funding marks a pivotal moment for Zinnia, enabling it to accelerate its market penetration…

Read More

Healthie Raises $23 Million in Series B to Drive Innovation in Virtual Healthcare

Editor04 mins

Healthie, a leading API-first platform for electronic health records (EHR), has announced the successful completion of a $23 million Series B funding round, led by TCV with participation from existing investors Birchmere, Velvet Sea Ventures, Greymatter, and Watershed. This strategic investment is set to accelerate Healthie’s mission to enhance virtual-first healthcare delivery, focusing on patient-centric…

Read More

RevOpsis Therapeutics Secures $1.8M NEI SBIR Grant to Propel Innovative Ophthalmic Therapies

Editor05 mins

In a significant advancement for ophthalmic medicine, RevOpsis Therapeutics, a pioneering biopharmaceutical firm, has been awarded a Small Business Innovation Research (SBIR) grant exceeding $1.8 million from the National Eye Institute (NEI), part of the National Institutes of Health (NIH). This funding will bolster the development of their lead asset, RO-104, aimed at treating neovascular…

Read More